Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

BTLS

Biotalys (BTLS)

Biotalys
일자:
정렬 기준:
 검색 관련기사 보기:EU:BTLS
일자시간출처헤드라인심볼기업
2024/05/0214:00GlobeNewswire Inc.Biotalys Starts Field Trials for Second BiofungicideEU:BTLSBiotalys
2024/04/3014:00GlobeNewswire Inc.Biotalys Appoints Laura J. Meyer to Board of DirectorsEU:BTLSBiotalys
2024/04/2401:00GlobeNewswire Inc.Results of the Ordinary and Extraordinary Shareholders’ MeetingEU:BTLSBiotalys
2024/03/3002:00GlobeNewswire Inc.Results of the Special Shareholders’ MeetingEU:BTLSBiotalys
2024/03/1815:00GlobeNewswire Inc.Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NGEU:BTLSBiotalys
2024/02/2702:00GlobeNewswire Inc.Invitation to a Special Shareholders’ MeetingEU:BTLSBiotalys
2024/02/2215:00GlobeNewswire Inc.Biotalys Reports Full-Year 2023 Financial Results and Business HighlightsEU:BTLSBiotalys
2024/02/0815:00GlobeNewswire Inc.Biotalys Enters into Academic Collaborations with Key Scientific Leaders in Europe and U.S.EU:BTLSBiotalys
2024/02/0102:00GlobeNewswire Inc.Information on the total number of voting rights and sharesEU:BTLSBiotalys
2024/01/2302:00GlobeNewswire Inc.Biotalys Notice of Full Year 2023 Results and Business HighlightsEU:BTLSBiotalys
2023/12/1915:00GlobeNewswire Inc.Biotalys Announces Results of Independent Field Trials in the U.S.EU:BTLSBiotalys
2023/11/2915:00GlobeNewswire Inc.Biotalys Provides Company UpdateEU:BTLSBiotalys
2023/10/0514:00GlobeNewswire Inc.Kevin Helash commences role as Chief Executive Officer of BiotalysEU:BTLSBiotalys
2023/10/0214:00GlobeNewswire Inc.Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phaseEU:BTLSBiotalys
2023/09/2614:00GlobeNewswire Inc.Biotalys announces participation at upcoming scientific, industry and investor eventsEU:BTLSBiotalys
2023/08/2314:00GlobeNewswire Inc.Biotalys Reports Half-Year 2023 Financial Results and Business HighlightsEU:BTLSBiotalys
2023/07/2014:00GlobeNewswire Inc.Invitation to a Special Shareholders’ MeetingEU:BTLSBiotalys
2023/07/0601:00GlobeNewswire Inc.Publication of transparency notificationEU:BTLSBiotalys
2023/06/1301:00GlobeNewswire Inc.Biotalys announces closing of private placementEU:BTLSBiotalys
2023/06/0714:00GlobeNewswire Inc.Biotalys Strengthens Relationship with Investors via Private Placement of New Shares for €7 millionEU:BTLSBiotalys
2023/05/3114:00GlobeNewswire Inc.Biotalys Continues to Demonstrate Strength of First Biocontrol in Latest Global Field TrialsEU:BTLSBiotalys
2023/04/2601:00GlobeNewswire Inc.Results of the Annual and Extraordinary Shareholders’ MeetingEU:BTLSBiotalys
2023/04/2414:00GlobeNewswire Inc.Syngenta and Biotalys enter into strategic partnership in biologicals innovation to advance solutions for sustainable agricultureEU:BTLSBiotalys
2023/03/2415:00GlobeNewswire Inc.Invitation to the Annual and an Extraordinary Shareholders MeetingEU:BTLSBiotalys
2023/03/1502:00GlobeNewswire Inc.Biotalys announces Chief Financial Officer succession planEU:BTLSBiotalys
2023/02/2815:00GlobeNewswire Inc.Biotalys Reports Full-Year 2022 Financial Results and Business HighlightsEU:BTLSBiotalys
2023/02/0102:00GlobeNewswire Inc.Information on the total number of voting rights and sharesEU:BTLSBiotalys
2023/01/2615:00GlobeNewswire Inc.Biotalys Achieves Significant Progress in Manufacturing Capabilities for EvocaEU:BTLSBiotalys
2023/01/0402:00GlobeNewswire Inc.Information on the total number of voting rights and sharesEU:BTLSBiotalys
2022/12/2802:00GlobeNewswire Inc.Results of the Extraordinary Shareholders’ MeetingEU:BTLSBiotalys
 검색 관련기사 보기:EU:BTLS